dc.creatorBarriga, Patricio
dc.creatorVanhauwaert, Paula
dc.creatorPorcile, Arnaldo
dc.date.accessioned2019-10-30T15:28:55Z
dc.date.available2019-10-30T15:28:55Z
dc.date.created2019-10-30T15:28:55Z
dc.date.issued2019
dc.identifierGynecological Endocrinology, Volumen 35, Issue 6, 2019, Pages 460-462
dc.identifier14730766
dc.identifier09513590
dc.identifier10.1080/09513590.2019.1576610
dc.identifierhttps://repositorio.uchile.cl/handle/2250/172409
dc.description.abstractToday health professionals are not only required to know medicine, but scientific reading, interpretation, and communication of new data. The new information about contraception and hormonal therapies must be analyzed by gynecologists to determine whether or not the new data are applicable to their patients and if it has an impact on their health. Recently a new study of hormonal contraceptives and the risk of breast cancer was published. In this study, the investigators found an elevation of the relative risk of breast cancers on the users versus the nonusers of hormonal contraception. After analyzing the publication and other data available, it is our opinion that it is a very low increase of the risk and its impact should be evaluated case by case, not forgetting to take into account the numerous beneficial effects that hormonal contraception have.
dc.languageen
dc.publisherTaylor and Francis Ltd
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceGynecological Endocrinology
dc.subjectbreast cancer
dc.subjectbreast cancer risk
dc.subjectHormonal contraception
dc.titleHormonal contraception and risk of breast cancer: a critical look
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución